Pfizer Inc.
The U.S. Food and Drug Administration has granted authorization for the Pfizer COVID vaccine for use in children ages 12 to 15, paving the way for widespread inoculations across the country. Multiple retailers, including Walmart, CVS, and Walgreens, have begun offering the vaccine at their pharmacies nationwide, with parents
Youth
As the American Heart Association (AHA) supports the new recommendations from the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), the country is gradually moving towards controlling the COVID-19 pandemic. The FDA's decision to authorize emergency use of the Pfizer-BioNTech
Youth
With the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) authorizing the Pfizer COVID-19 vaccine for adolescents aged 12-15, the path towards safely reopening schools and communities is now clearer. This development marks a significant milestone in the fight against the pandemic, allowing millions of
Pfizer Inc.
The Food and Drug Administration has granted emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years, marking a significant milestone in the country's vaccination efforts. This expansion of vaccine eligibility offers protection against COVID-19 for millions of children during summer activities and raises hopes
Johnson & Johnson
The US Department of Veterans Affairs has decided to temporarily halt the administration of the Johnson & Johnson (Janssen) COVID-19 vaccine due to concerns raised by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA). This precautionary measure prioritizes the safety of veterans,
Johnson & Johnson
Ohio State University's Wexner Medical Center has administered over 163,000 COVID-19 vaccine doses since December 14, with only 1,116 being the Johnson and Johnson/Janssen (JandJ) vaccine. The pause in the use of the JandJ vaccine was announced by the U.S. Food and Drug Administration
COVID-19 vaccines
US Food and Drug Administration vaccine advisers will meet Friday to discuss the potential emergency authorization of Johnson & Johnson's single-dose coronavirus vaccine. The vaccine has shown to be 66% effective in preventing moderate to severe COVID-19 disease and 85% effective in preventing severe disease. The FDA has
COVID-19 vaccines
The United States is slowly moving forward with its COVID-19 vaccination efforts, with two new vaccine candidates poised to enter the spotlight. Johnson & Johnson's single-shot vaccine is expected to receive FDA approval as early as tomorrow, while Novavax's candidate is aiming to apply for emergency
COVID-19 vaccines
Alibaba Group Holding Ltd. faced a devastating day on the market as its shares plummeted lower after Chinese regulators set their sights on the tech giant in a fresh attack on the financial empire of billionaire Jack Ma. The turbulence sent shockwaves through the stock market, with several other tech
COVID-19 vaccines
Regulatory Affairs Professionals Society released daily news and intelligence briefings, covering major regulatory, biopharma, and medtech stories from around the globe. Key storylines include the US CDC panel endorsing Moderna vaccine for Americans, vaccine distribution efforts, and approvals of new treatments and medications. Key Takeaways: * The US CDC panel has
COVID-19
The Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, marking a significant milestone in the fight against the pandemic. This decision clears the way for widespread vaccinations to begin, with Phase 1A prioritizing healthcare personnel and long-term care facilities. Pennsylvania'
Pharmaceutical industry
The US Food and Drug Administration has granted emergency use authorization to Pfizer and BioNTech's COVID-19 vaccine, BNT162b2, for individuals 16 years of age or older, paving the way for a mass vaccination campaign in the US. This development is a significant milestone in the fight against the
